However, different criteria for the inclusion of patients have been used in these trials, and different conclusions have been drawn about which patients are suitable for thrombolytic treatment.6 There were also great discrepancies between the numbers of patients evaluated for inclusion and the numbers finally randomized in the three largest trials (Table 1) .
Consequently, the beneficial effect of thrombolysis is well established, but the proportion of patients See p 1510 with suspected acute myocardial infarction eligible for such treatment is less clear.
The purpose of this paper is to show how the percentage of patients with strongly suspected or Table 2 shows the numbers of patients and confirmed infarctions in total and in patients with an initially strong suspicion of myocardial infarction (that is, in categories 1 and 2). The patients with a strong suspicion of infarction made up only 24% of the unselected population, but 79% of all infarctions developed in this group. Table 3 shows the characteristics of the 1,715 patients with a strong suspicion of myocardial infarction. Figure 1 shows the same patients divided into groups according to initial electrocardiographic pattern and the numbers of confirmed infarctions in each such group. It should be noted that the electrocardiographic patterns used in Figure 1 are not the same as the criteria defined in "Methods," which are those we have used in our further analysis. Figures 2-4 show the results of our analysis. They refer only to the patients in categories 1 and 2 (that is, obvious or strongly suspected acute infarction).
The percentages of 1,715 patients with a strong suspicion of myocardial infarction who would have been eligible for thrombolytic treatment depending on the electrocardiographic and delay time criteria applied are as follows. As shown in Figure 2 The percentages of treated patients, among 1,715 patients with a strong suspicion of myocardial infarction, developing a confirmed myocardial infarction are as follows. Figure 3 shows that, depending on the electrocardiographic and delay time criteria used, between 44% and 91% of the patients considered eligible for treatment would actually have developed a confirmed infarction.
The percentages of 723 patients with an initially strong suspicion of myocardial infarction, and who subsequently developed a confirmed myocardial infarction, who would have been eligible for thrombolytic treatment are as follows. As shown in Figure 4 , depending on the electrocardiographic and delay time criteria used, between 28% and 92% of the patients who developed a myocardial infarction would have been treated with intravenous thrombolysis.
In most of the subgroups in Figures 2 and 4 , about 50-60% of those considered eligible for thrombolysis were transported to hospital by ambulance. Thus, eligibility for prehospital thrombolysis in each subgroup can be roughly calculated by dividing the percentage values given in Figures 2 and 4 by two.
Discussion
Because most myocardial infarctions appear to be caused by an occlusive thrombus in the infarctrelated coronary vessel,8 intense attempts have been made with intracoronary and intravenous thrombolytic agents to dissolve such thrombi. Large randomized trials have shown that it is possible to limit infarct size9-12 and to reduce mortality considerably3-5 by early intervention with intravenous thrombolysis in myocardial infarction, and the frequency of serious side effects seems to be reasonably low. In the studies that have evaluated thrombolytic treatment, varying inclusion criteria have been used, and some discrepancies have been observed in terms of outcome in subgroup analyses.
In this study we have included patients with sudden onset of heart failure and unstable angina pectoris, regardless of the electrocardiogram. The reason for this is that we wanted to include as many patients with development of infarction as possible in the material, and it is impossible to exclude infarct Regarding the time from onset of symptoms, maximal durations of 5, 12, and 24 hours, respectively, were stated in the protocols of the three largest trials3-5 (Table 1) . Based on the results of the GISSI trial, it was suggested that little benefit was observed if thrombolysis was started more than 6 hours after the onset of symptoms and that the greatest benefit was observed if treatment was started within 3 4 Delay times in suspected acute myocardial infarction vary somewhat between countries. For the patients in the present study, the median delay time was 3 hours. This figure is fairly similar to those found in many other countries,13 but one hopes that delay times will be reduced in the future. 14 The initial electrocardiographic pattern seems to be related to prognosis in myocardial infarction. Thus, patients having pathological changes on the admission electrocardiogram have a higher mortality than patients having no such changes.15 '16 In many of the studies evaluating the effect of early thrombolysis, only patients having ST segment elevation on the electrocardiogram were included.9'17-21 In the ISIS-2 and ASSET studies, patients were included regardless of the pattern on the initial electrocardiogram.45 Even if most of the included patients had, in fact, signs of ischemia on the electrocardiogram, these studies did not indicate that treatment should be given only to patients with initial ST elevation. In the GISSI and ISIS-2 studies, however, no beneficial effect was observed in patients having ST depression only,3,4 and in the ASSET study, this issue was not evaluated. 5 When thrombolytic treatment is used in suspected acute myocardial infarction, some patients without infarction will receive treatment. These patients are exposed to the risk of side effects but will probably have no benefit from the treatment. The number of such patients is greatly influenced by the electrocardiographic criteria used (Figure 3 ). However, these percentages were found in randomized studies, where the criteria for randomization often differ from the criteria for treatment in everyday clinical practice. For example, some criteria for exclusion in randomized studies are of an administrative nature. Furthermore, the populations from which patients in these large trials were recruited have not been adequately described, and thus, it is difficult to draw firm conclusions from the results. Therefore, from a totally unselected population of consecutive patients with a strong suspicion of acute myocardial infarction in the emergency ward, we have tried to calculate the proportions of patients eligible for intravenous thrombolysis when various electrocardiographic and delay time criteria are applied. Depending of the criteria chosen, between 13% and 91% of such patients are eligible for treatment ( Figure 2) ; between 28% and 92% of such patients who actually develop a confirmed infarction would receive thrombolytic treatment ( Figure 4) ; and between 44% and 91% of such patients found to be eligible for treatment would actually develop a confirmed myocardial infarction ( Figure 3) .
In another evaluation of eligibility for thrombolytic treatment,25 which used the criteria age 75 years or less electrocardiogram suggestive of infarction, and time from onset of symptoms 4-6 hours, 23-25% of infarct patients were eligible before contraindications were considered.
One could argue that the number of patients actually developing myocardial infarction may be related to whether thrombolysis is given or not because in theory thrombolysis may prevent infarct development if given very early. This hypothesis has, however, not been confirmed in clinical trials, and our own experience does not indicate that very early thrombolysis prevents infarct development.7
In conclusion, from large randomized studies, it is unclear what proportion of patients is eligible for treatment with thrombolytic agents. We find that, depending on the electrocardiographic and delay time criteria used, the proportion of patients eligible for thrombolysis varies widely as does the proportion of confirmed infarctions that will receive treatment and the proportion of patients treated who actually develop an infarction. The proportions of treated patients actually developing a confirmed infarction seem to be mainly influenced by the electrocardiographic criteria used.
